Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D08HIH
|
|||
Former ID |
DIB001036
|
|||
Drug Name |
ERB-196
|
|||
Synonyms |
WAY-196; WAY-202196; Estrogen receptor beta agonist (oral, inflammation/sepsis), Wyeth
Click to Show/Hide
|
|||
Indication | Inflammatory bowel disease [ICD-11: DD72; ICD-10: K50-K52] | Discontinued in Phase 1 | [1] | |
Company |
Wyeth
|
|||
Structure |
Download2D MOL |
|||
Formula |
C17H10FNO2
|
|||
Canonical SMILES |
C1=CC(=CC2=C(C=C(C=C21)C3=CC(=C(C=C3)O)F)C#N)O
|
|||
InChI |
1S/C17H10FNO2/c18-16-7-10(2-4-17(16)21)12-5-11-1-3-14(20)8-15(11)13(6-12)9-19/h1-8,20-21H
|
|||
InChIKey |
NSSOSHDCWCMNDM-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 550997-55-2
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Estrogen receptor beta (ESR2) | Target Info | Agonist | [2] |
KEGG Pathway | Estrogen signaling pathway | |||
Prolactin signaling pathway | ||||
Pathway Interaction Database | Plasma membrane estrogen receptor signaling | |||
Validated nuclear estrogen receptor beta network | ||||
Validated nuclear estrogen receptor alpha network | ||||
Reactome | Nuclear Receptor transcription pathway | |||
WikiPathways | SIDS Susceptibility Pathways | |||
Ovarian Infertility Genes | ||||
Integrated Pancreatic Cancer Pathway | ||||
Nuclear Receptors |
References | Top | |||
---|---|---|---|---|
REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800021229) | |||
REF 2 | WAY-202196, a selective estrogen receptor-beta agonist, protects against death in experimental septic shock. Crit Care Med. 2006 Aug;34(8):2188-93. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.